Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
https://www.zacks.com/stock/news/2306385/eli-lilly-lly-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2306385
Jul 22, 2024 - In the most recent trading session, Eli Lilly (LLY) closed at $865.97, indicating a +0.99% shift from the previous trading day.
0
Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?
https://www.fool.com/investing/2024/07/20/can-2-biotechs-beat-eli-lilly-and-novo-nordisk/?source=iedfolrf0000001
Jul 20, 2024 - At least one of the pair has a credible shot at finding a home in the market.
0
Eli Lilly, Novo extend muti-day decline in rare selloff
https://seekingalpha.com/news/4125589-eli-lilly-stock-novo-stock-rare-selloff?source=feed_sector_healthcare
Jul 18, 2024 - Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock witness a selloff after positive trial data for an oral weight loss drug from Roche (RHHBY). Read more here.
0
Eli Lilly names Gordon Brooks as interim CFO
https://seekingalpha.com/news/4123281-eli-lilly-names-gordon-brooks-as-interim-cfo?source=feed_sector_healthcare
Jul 10, 2024 - Eli Lilly appoints Gordon Brooks as interim CFO, replacing Anat Ashkenazi who will join Alphabet.
0
Eli Lilly (LLY) to Buy Morphic for $3.2B, Boost IBD Presence
https://www.zacks.com/stock/news/2298543/eli-lilly-lly-to-buy-morphic-for-3-2b-boost-ibd-presence?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2298543
Jul 09, 2024 - Eli Lilly's (LLY) acquisition of Morphic (MORF) is set to expand its immunology pipeline by adding the latter's lead candidate, MORF-057, which is being developed for IBD conditions.
0
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
https://www.fool.com/investing/2024/07/09/can-eli-lilly-surpass-1000-this-year/?source=iedfolrf0000001
Jul 09, 2024 - This pharma company is posting double-digit revenue growth.
0
San Diego biotech news: Eli Lilly inks deal that could lead to $1B acquisition of this local company
https://www.sandiegouniontribune.com/2024/07/08/san-diego-biotech-news-eli-lilly-inks-deal-that-could-lead-to-1b-acquisition-of-this-local-company/
Jul 08, 2024 - San Diego's Radionetics inked deal with Eli Lilly to advance its oncology pipeline
0
If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
https://www.zacks.com/stock/news/2297887/if-you-invested-1000-in-eli-lilly-a-decade-ago-this-is-how-much-it-d-be-worth-now?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2297887
Jul 08, 2024 - Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
0
Here’s why Eli Lilly, Pfizer and J&J are in San Diego looking for the next big drug
https://www.sandiegouniontribune.com/2024/07/05/heres-why-eli-lilly-pfizer-and-jj-are-in-san-diego-looking-for-the-next-big-drug/
Jul 05, 2024 - Will local startups give big pharma its next blockbuster drug? Eli Lilly and Pfizer are launching new biotech incubators in San Diego.
0
Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
https://www.fool.com/investing/2024/07/05/missed-out-on-eli-lilly-this-much-smaller-biotech/?source=iedfolrf0000001
Jul 05, 2024 - Could Zealand Pharma be a better option for growth-oriented investors?
0